Cancer Vaccine; Trial to study response to adjuvant therapy with melanoma cancer vaccine
Cancer Vaccine; Trial to study response to adjuvant therapy with melanoma cancer vaccine
About this item
Full title
Cancer Vaccine; Trial to study response to adjuvant therapy with melanoma cancer vaccine
Publisher
Atlanta: NewsRx
Journal title
Vaccine Weekly, 2005, p.26
Language
English
Formats
Publication information
Publisher
Atlanta: NewsRx
Subjects
More information
Scope and Contents
Contents
Norwood Immunology has licensed its immunology intellectual property to TAP Pharmaceutical Products Inc. for commercialization in the United States, utilizing TAP's GnRH analogue, Lupron Depot (leuprolide acetate for depot suspension). This combined initiative is exploring the use of Lupron Depot in regenerating the thymus gland and in turn "reboot...
Alternative Titles
Full title
Cancer Vaccine; Trial to study response to adjuvant therapy with melanoma cancer vaccine
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_211271053
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_211271053
Other Identifiers
ISSN
1074-2921
E-ISSN
1532-4702
How to access this item
Log in as a Library member
